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Abstract
With the purpose to elucidate further the properties of the supernatant F4 obtained by centrifu-
gation at 100, 000 g from the regional lymph node cells of the Cb mice sensitized with EHRLICH
ascites tumor cells, the supernatant (cf. Report 13) was subjected to the following treatments:. The
supernatant (F4) was first diluted variously with Hanks solution. 2. F4 was passed through Seitz
filter. 3. Heated at 56◦C for 30 minutes. 4. It was frozen and thawed. 5. Treated with O. 01 96
trypsin solution. Each of F4 frations so treated was used in the tissue culture of JTC-II cells (de-
rived from EHRLICH cancer cells) as target cells. As a result we found that the antitumor factor
passes th rough Seitz filter, and it loses its antitumor activity by 4-fold dilution or over. Likewise
F4 loses its activity by freezing-thawing treatment as well as by trypsin treatment, while by heat
treatment at 56◦C for 30 minutes, it still retains its activity. From these finding, it is assumed that
the antitumor factor contained in F4, fraction is not serum antibody but is a protein associated with
the cell membrane.
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As described in the previous paper (13), the subcellular fraction isolated
from the regional lymph node cells of the mouse sensitized with Ehrlich
ascites tumor cells has antitumor effect on the proliferation of the tumor
cells. Further, it has been confirmed that such sensitized lymph node cells
lose the antitumor activity after being treated with trypsin. From these
two facts it is deduced that the antitumor factor of the sensitized lymph
node cells is the immuno-protein adhered to the surface of the cell mem-
brane.
For the purpose to elucidate the property of this antitumor factor,
biological and physical properties of this substance were studied in the
present experiment. As already been explained in the previous report, the
supernatant fraction (F4, at 100,000 g) shows a more marked antitumor
activity and is easier to handle than the sediment fraction (F2, at 8,500 g),
hence this supernatant fraction was used in the present experiment.
MATERIALS AND METHODS
Animals: Just as in the previous experiment (13), Cb mice weighing around
20 g were employed.
Tumor cells: The cells used for transplantation were Ehrlich ascites tumor
cells. These were the'tumor cells maintained at the Department of Pathology,
Okayama University by passing successively through the peritoneal cavity of Cb
mice.
Culture cells: The culture cells used were Ehrlich ascites tumor cells (regis-
tered as JTC-II strain).
Sensitization: Ehrlich ascites tumor cells (5 x 106 JTC-II cells) were trans-
planted subcutaneously on the back between the scapulas.
Fractionation method: Two weeks after tumor transplantation, lymph nodes
were removed from both sides of the neck and axilla of the mice, washed in cold
Hanks solution, subjected to homogenization in a glass homogenizer by 5 rapid
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strokes of revolution and further subjected to 7 strokes of homogenization in a
homogenizer of Potter-Elevehjein type while revolving the pestle with teflon
head at a high speed to obtain homogenate. The medium in this instance was
Hanks solution. To obtain the supernatant fraction, these homogenates were
centrifuged at 100, OOOg for 60 minutes. The supernatant thus obtained is taken as
the antitumor factor of the sensitized lymph node cells and is used in the following
experiments. This supernatant corresponds to F4 fraction and has antitumor
activity on lTC-II cells as mentioned in the previous report.
Tissue culture: Of 10 ml supernatant treated in various ways (as will be later
explained), 2 ml of it is used for the tissue culture. Two ml supernatant, 6ml
YLE solution and 2 ml bovine serum are mixed and to this mixture, 10,000-
20,000 cells/ml of lTC-II cells are added and 1.5 ml of the mixture is placed
separately in test tubes at the angle of 5°, and the stationary culture is con-
ducted for 24 and 48 hours at 37°C.
Cell counting: By decanting the short test tubes gently the medium is dis-
carded after 24- and 48-hour culture, 1.5 ml of crystal violet solution is then
poured into the test tube to stain the culture cells attached on the vessel wall,
and the cell counts are taken with Biirker-Tiirk hemocytometer, taking the
average of three test tubes each time.
Treatment of the supernatant (F4 ): For the purpose to find out the properties of
the F4 fraction, it is treated in various ways as follows:
1. Multiple dilutions: Two ml of supernatant is diluted with Hanks solution
by the two-fold dilution method. Supernatant used was prepared in 9 ml volume
from 1.02g lymph node (taken from 13 mice), and by the micro-Kyeldahl method
the supernatant proved to contain 3.312 mg/ml of protein. By adding 2 ml of
each dilution to the medium the tissue culture is conducted. In each tube, 10,000
cells/ml are added.
2. Passing the supernatant through Seitz filter: From the 15 sensitized mice 18
ml of the supernatant is prepared by the method described in the foregoing. Of
this 18 ml supernatant, 16 ml is passed through Seitz filter asceptically, and the
filtered and unfiltered supernatants (2 ml) are separately used in tissue culture for
the comparison of their results.
3. Heat treatment of the supernatant: The sensitized supernatant is asceptically
incubated in a hot water bath of 56°C for 30 minutes while stirring. Then 2 ml
of this heat-treated supernatant is mixed with lTC-II cells and cultured.
4. Freezing-thawing of the supernatant: The sensitized supernatant is left stand-
ing at the temperature of -20°C for one hour to freeze it, and is thawed in a
hot water bath of 37°C to be used for the lTC-II cell mixed culture.
5. Trypsin treatment of the supernatant: To 2 ml of the sensitized supernatant
is added 2 ml of 0.01 % trypsin GKN solution, and after leaving this mixture in
a warm room for one hour, the tissue culture with lTC-II cells is carried out.
6. Control groups: To five test groups mentioned so far, 2 ml of the super-
natant obtained from normal mouse lymph node cells are mixed with lTC-II
cells and cultured as the controls.
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1. Multiple dilution of the sensitized supernatant (F;.): As shown in Fig.
1, the sensitized supernatant exhibits antitumor activity up to the two-fold
dilution, but from the 4-fold dilution on, there is no significant difference
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Fig. I. Multiple dilution of supernatant
I) Control, only JTC-ll cells. 2) Supernatant (l00, 000 X g) of
sensitized lymphnode cells 3) Two-fold dilution. 4). 4-fold
dilution. 5) 8-fold dilution. 6) 16·fold dilution. 7) 32.fold
dilution.
2. Filtration: The supernatant passed through the filter has the
inhibitory effect on the proliferation ofJTC-II cells just as the sensitized
supernatant, showing a distinct difference from the control group. Namely,
the antitumor factor in the supernatant has passed through Seitz filter.
(Fig. 2).
3. As the heat treatment, freezing-thawing and the trypsin treatment
have been done simultaneously in the same experiment, the results are
summarized in Fig. 3. As is obvious from the figure, the supernatant
heated at 56°C for 30 minutes still has the antitumor activity and inhibits
the proliferation of JTC-II cells. In contrast, the supernatant frozen at
- 20°C and thawed, has lost its antitumor activity, and likewise the one
3
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Fig. 2. Pathway taken by the supernatant of sensitized lymph node
cells through the Seitz filter apparatus
1) Control, only ]TC-II cells. 2) The supernatant that passed
through Seitz filter. 3) Addition of untreated supernatant.
treated with 0.01 % tyrpsin-GKN solution has lost its antitumor activity,
both differing not significantly from the control groups.
DISCUSSION
As has been demonstrated in the present experiments, since the anti-
tumor factor passes through the Seitz filter and it loses its antumor activity
when treated with trypsin, this factor seems to be closely associated with
protein. Furthermore, as the supernatant does not lose its activity even
after heat treatment at 56°C for 30 minutes, and no complement has
been added in the present experiment, the antitumor factor contained in
the supernatant seems to differ from cytotoxic antibody dependent upon
complement that shows cell lysis.
HANAoKA (1, 2) studied cytotoxic effect of the supernatant fraction
(100,000 g, 120 min) prepared from the membrane component of the
lymphoid cells from AIJax mice sensitized with SCL cells and treated
with sodium deoxycholate and supersonicated. He determined the cyto-
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Fig. 3. Antitumor effect of treated supernatant
1) Control, only JTC-II cells. 2) Addition of the sensitized super-
natant. 3) Addition of the supernatant from normal lymph node
cells. 4) Addition of the supernatant previously heated at 56°C
for 30 minutes. 5) Addition of the supernatant previous frozen
at - 20°C. 6) Addition of trypsin-treated supernatant.
toxic activity by counting the number of surviving 8CL cells after incuba-
ting 8CL cells suspended in the medium of the supernatant plus comple-
ment for 2· hours at 37°C. He claims that without complement such
cytotoxic activity is lost. Therefore, the antitumor factor as observed in
the present experiments distinctly differs from that of HANAoKA. The
cytotoxin contained in the membrane component (as in the case of HANA-
OKA) is in 198 fraction and is quite different from 78 globulin normally
found in serum antibody. HANAoKA used as his starting material the
membrane component of the lymph node cells super-immunized with
lymphoid leukemic cells, whereas in our experiment we used as the starting
material the lymph node 2 weeks after the transplantation of Ehrlich
ascites tumor cells of epitheloid nature, sensitized relatively insufficiently.
For this reason there can be seen some difference from the results of
HANAOKA. However, in view of the fact that the antitumor factor loses
its activity by trypsin treatment, that it passes through the diffusion
5
Nakashima: Antitumor factors of regional lymph node cells in the
Produced by The Berkeley Electronic Press, 1969
224 Y. NAKASHIMA
chamber, and that, when EHRLICH ascites tumor cells are cultured with
regional lymph node cells, these lymph node cells aggregate onto the
surface of EHRLICH ascites tumor cells leading the latter to destruction,
the antitumor factor obtained in the present experiment seems to be also
bound to the membrane component.
According to HARA (II), he has observed antitumor substance also in
the serum of the mouse at the time of transplantation of EHRLICH ascites
tumor cells. There is a possibility that such a substance in serum, being
attached on the surface of lymph node cells, acts as a cellular antibody,
the so-called cytophilic antibody (3, 4). GOVAERT (1960) (5) reported that
by the action of humoral antibody normal cells acquire cytotoxicity. How-
ever, in view of the fact that in the incubation of normal mouse lymph
node cells with the serum obtained 10 days after the transplantation of
EHRLICH ascites tumor cells from the sensitizied mouse, the lymph node
cells did not acquire antitumor activity, and that no cytotoxic antibody
could be demonstrated in lymph node cells as reported by PERLMAN and
BROBERGER (6) (1963), GRANGER and WEISSER (1964) (7), MOLLER (1965) (8)
in their precise experiments, the antitumor factor of regional axillary
lymph node cells obtained after EHRLICH tumor transplantation seems not
to be the antibody of circulating blood, that has become attached onto the
cell surface. AKIYAMA (9) studied the appeararance of antibody in his
heterotransplantation of rat ascites hepatoma cells to mice and he noted
that IgM of 19S of a substance similar to it is attached onto lymphoid
cells, but no IgM that has antitumor activity is found in serum. This
may be due to the heterotransplnatation where gene differs markedly.
NAJARIAN and FELDMAN (1963) (10) isolated lymphoid cells from the
spleen and lymph nodes of CBA mice sensitized with skin graft of A
mouse, and prepared the supernatant fraction from these cells by super-
sonication and centrifugation at 3, 000 rpm. They demonstrased that it is
possible to accomplish passive transfer of immunity with the use of such a
supernatant. They further state that the soluble component of the serum
is resistant to O. 1M 2-mercaptoethanol and has the slow sedimentation
coefficient of about 6, resembling the so-called 7S rglobulin. However,
they have not clarified what effect this supernatant would have on the
target cell in vitro. It is interesting to note that antibody-like substance con-
cerned with transplantation immunity has been extracted from sensitized
lymphoid cells and that such a substance resembles globulin. It is not
possible to draw any definitive conclusion whether the antitumor factor
that is liberated from the regional lymph node cells and after passing
through the diffusion chamber, acts inhibitorily on the growth of EHRLICH
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tumor cells as suggested by HARA in 1965 (11) is identically the same
substance as the antitumor factor contained in the supernatant of the
subcellular component of lymph node cells of the present experiment.
However, from the fact that either one of such a factor wields antitumor
activity without complement and that both viable lymph node cells and
the supernatant are inactivated by trypsin treatment, and from the data
presented by various workers, the substance that shows an inhibitory
effect on lTC-II cells seems to be a protein that can be liberated to some
extent from the cell membrane of lymph node cells, and such a substance
will be a component of the cell membrane or a substance attached to the
membrane. Further, as reported by MANNAMI (1968) (12) the fact that
the sensitized lymph node cells in vitro aggregated on lTC.II cells, fused
with each other and both cells were destroyed seems to suggest the presence
of antitumor substance in the cell membrane of sensitized lymph node
cells.
SUMMARY
With the purpose to elucidate further the properties of the super-
natant F4 obtained by centrifugation at 100, 000 g from the regional
lymph node cells of the Cb mice sensitized with EHRLICH ascites tumor
cells, the supernatant (cf. Report 13) was subjected to the following treat-
ments:
1. The supernatant (F4) was first diluted variously with Hanks solu-
tion. 2. F4 was passed through Seitz filter. 3. H~ated at 56°C for 30
minutes. 4. It was frozen and thawed. 5. Treated with O. 01 96 trypsin
solution. Each of F4 frations so treated was used in the tissue culture of
lTC-II cells (derived from EHRLICH cancer cells) as target cells. As a result
we found that the antitumor factor passes th rough Seitz filter, and it
loses its antitumor activity by 4-fold dilution or over. Likewise F4 loses
its activity by freezing-thawing treatment as well as by trypsin treatment,
while by heat treatment at 56°C for 30 minutes, it still retains its activity.
From these finding, it is assumed that the antitumor factor contained
in F., fraction is not serum antibody but is a protein associated with the
cell membrane.
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